8.61 USD
▼-0.53-5.80%
盘后 9.34 0.00%
2026-09-15
市值
$2.00B
市盈率
12.74
EPS
0.70
股息率
—
52 周区间
7.21 – 20.46
成交量
3.59M
Beta
0.78
目标价
17.00
52W 低 7.2152W 高 20.46
价格走势
公司简介
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal anti...